152 related articles for article (PubMed ID: 30736983)
41. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
[TBL] [Abstract][Full Text] [Related]
42. Genomic instability in invasive breast carcinoma measured by inter-Simple Sequence Repeat PCR.
Stoler DL; Bartos JD; Swede H; Edge SB; Winston JS; Wiseman SM; Anderson GR
Breast Cancer Res Treat; 2006 May; 97(1):107-10. PubMed ID: 16319977
[TBL] [Abstract][Full Text] [Related]
43. DNA mismatch repair and the transition to hormone independence in breast and prostate cancer.
Martin L; Coffey M; Lawler M; Hollywood D; Marignol L
Cancer Lett; 2010 May; 291(2):142-9. PubMed ID: 19896265
[TBL] [Abstract][Full Text] [Related]
44. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.
Calza S; Hall P; Auer G; Bjöhle J; Klaar S; Kronenwett U; Liu ET; Miller L; Ploner A; Smeds J; Bergh J; Pawitan Y
Breast Cancer Res; 2006; 8(4):R34. PubMed ID: 16846532
[TBL] [Abstract][Full Text] [Related]
45. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
Ellsworth DL; Ellsworth RE; Love B; Deyarmin B; Lubert SM; Mittal V; Shriver CD
Breast Cancer Res Treat; 2004 Nov; 88(2):131-9. PubMed ID: 15564796
[TBL] [Abstract][Full Text] [Related]
46. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
47. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Stankovic T; Milinkovic V; Bankovic J; Dinic J; Tanic N; Dramicanin T; Tanic N
Biomed Pharmacother; 2014 Jun; 68(5):521-6. PubMed ID: 24767865
[TBL] [Abstract][Full Text] [Related]
48. MYC amplification and TERT expression in breast tumor progression.
Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
[TBL] [Abstract][Full Text] [Related]
49. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
50. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies.
Lee JK; Choi YL; Kwon M; Park PJ
Annu Rev Pathol; 2016 May; 11():283-312. PubMed ID: 26907526
[TBL] [Abstract][Full Text] [Related]
52. Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells sing Comet-FISH.
Kumaravel TS; Bristow RG
Breast Cancer Res Treat; 2005 May; 91(1):89-93. PubMed ID: 15868435
[TBL] [Abstract][Full Text] [Related]
53. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
Liu C; Wang X; Genchev GZ; Lu H
Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
[TBL] [Abstract][Full Text] [Related]
54. Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.
Focken T; Steinemann D; Skawran B; Hofmann W; Ahrens P; Arnold N; Kroll P; Kreipe H; Schlegelberger B; Gadzicki D
Cytogenet Genome Res; 2011; 135(2):84-92. PubMed ID: 22024613
[TBL] [Abstract][Full Text] [Related]
55. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.
Eroles P; Bosch A; Pérez-Fidalgo JA; Lluch A
Cancer Treat Rev; 2012 Oct; 38(6):698-707. PubMed ID: 22178455
[TBL] [Abstract][Full Text] [Related]
56. Genetic stability of tumor microenvironment.
Danish M; Sissung T; Price DK; Figg WD
Cancer Biol Ther; 2008 Mar; 7(3):331-2. PubMed ID: 18362517
[No Abstract] [Full Text] [Related]
57. Risk Factors and Preventions of Breast Cancer.
Sun YS; Zhao Z; Yang ZN; Xu F; Lu HJ; Zhu ZY; Shi W; Jiang J; Yao PP; Zhu HP
Int J Biol Sci; 2017; 13(11):1387-1397. PubMed ID: 29209143
[TBL] [Abstract][Full Text] [Related]
58. Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy.
Yu Z; Song M; Chouchane L; Ma X
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34208889
[TBL] [Abstract][Full Text] [Related]
59. Recent perspectives of breast cancer prognosis and predictive factors.
Cao SS; Lu CT
Oncol Lett; 2016 Nov; 12(5):3674-3678. PubMed ID: 27900052
[TBL] [Abstract][Full Text] [Related]
60. Genetics and Breast Cancer - Oncologists Perspectives.
Naik R; Veldore VH; Gopinath KS
Indian J Surg Oncol; 2015 Dec; 6(4):415-9. PubMed ID: 27065667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
